APT Medical Inc.
688617
株式のランク
#3232
APT Medical Inc. is a global enterprise dedicated to the research, development,... APT Medical Inc. is a global enterprise dedicated to the research, development, production, and commercialization of invasive interventional medical devices primarily targeting cardiovascular and cerebrovascular diseases. Its extensive product portfolio encompasses a range of electrophysiological tools, including catheter delivery systems, alongside radiofrequency ablation and mapping catheters. Additionally, APT Medical provides various vascular intervention solutions, spanning diagnostic and therapeutic devices, as well as essential intervention accessories. Beyond its proprietary offerings, the company extends its expertise through OEM (Original Equipment Manufacturer) and ODM (Original Design Manufacturer) services for catheter and metal-based products, including associated accessories. Established in 2002, APT Medical maintains its corporate headquarters in Shenzhen, China.
株価
$38.62
時価総額
$5.47B
変化（1日）
0.19%
変化（1年）
-17.07%
国
CN
取引 APT Medical Inc. (688617)
カテゴリー
Healthcare
APT Medical Inc.（688617）の配当利回りの履歴
APT Medical Inc.（銘柄コード: 688617）の配当利回り（TTM）は2024-12-31時点で0.37%です。
過去5年間の平均配当利回り: 0.36%
過去5年間の平均配当利回り: 0.36%
APT Medical Inc.（688617）の2017から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
| 年 | 配当利回り | 変化 |
|---|---|---|
| 2026 (TTM) | 0.39% | -22.00% |
| 2025 | 0.50% | 35.14% |
| 2024 | 0.37% | -15.91% |
| 2023 | 0.44% | 37.50% |
| 2022 | 0.32% | 77.78% |
| 2021 | 0.18% | 1,700.00% |
| 2020 | 0.01% | -66.67% |
| 2019 | 0.03% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.00% | 0.00% |
類似企業または競合他社の配当利回り（TTM）
| 企業 | 配当利回り | 国 |
|---|---|---|
| 2.51% |
US
|
|
| 3.02% |
IE
|
|
| 1.14% |
US
|
|
| 0.00% |
US
|
|
| 2.39% |
DE
|
